Si isn't testing anyone's patience.
Really ? Then please explain to me how an "Exclusive" Remestemcel-L agreement with Novartis in November suddenly enables "discussions with potential strategic partners" for Remestemcel-L for respiratory diseases ?? I'm all ears
Key initiatives and upcoming milestones for the next two quarters:
• Mesoblast’s strengthened balance sheet will underpin the Company’s operational preparedness and its ongoing discussions with potential strategic partners to develop and commercialize rexlemestrocel-L and remestemcel-L for the large market opportunities of chronic heart failure, chronic lower back pain, and respiratory diseases
Is this sentence full of obfuscation so that in a couple of months they can say "we basically told you the Novartis deal was on the rocks back in March" ? lol
https://hotcopper.com.au/threads/an...g-milestones.5985592/page-21?post_id=52164892
Ann: Mesoblast Operational Highlights and Upcoming Milestones, page-34
-
- There are more pages in this discussion • 144 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
0.045(4.00%) |
Mkt cap ! $1.335B | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.18 | $1.13 | $4.980M | 4.315M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 73090 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 27903 | 1 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |